Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$616,538
-$60,381 QoQ
Shares Held
4,880
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,284
of 2,266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Moss Adams Wealth Advisors LLC holds $15,875,041 across 8 Drug Manufacturers - General names. GILD ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,778 | $5,730,876 | |
| 2 | JNJ |
Johnson & Johnson
|
12,601 | $3,200,275 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,057 | $1,934,824 | |
| 4 | ABBV |
AbbVie Inc.
|
7,424 | $1,868,174 | |
| 5 | AMGN |
Amgen Inc
|
4,043 | $1,464,050 | |
| 6 | PFE |
Pfizer Inc
|
28,570 | $687,965 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
4,880 | $616,538 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,462 | $372,339 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $616,538 | 4,880 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $676,919 | 4,857 | Shares | Other | 2026-04-23 | |
| 2025-12-31 | $545,701 | 4,446 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $485,070 | 4,370 | Shares | Other | 2025-10-21 | |
| 2025-06-30 | $465,431 | 4,198 | Shares | Other | 2025-07-17 | |
| 2025-03-31 | $414,584 | 3,700 | Shares | Other | 2025-04-14 | |
| 2024-12-31 | $287,639 | 3,114 | Shares | Other | 2025-01-15 | |
| 2024-09-30 | $214,546 | 2,559 | Shares | Other | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||